Energy Vault Holdings, Inc. Receives Notice of Continued Listing Standards From NYSE

Rhea-AI Summary

Energy Vault Holdings (NYSE: NRGV) has received a notice from the New York Stock Exchange (NYSE) on April 16, 2025, indicating non-compliance with continued listing standards due to its average closing stock price falling below $1.00 over a consecutive 30-day trading period.

The company has been granted a six-month cure period to regain compliance with the NYSE's minimum stock price requirement. Energy Vault plans to notify NYSE by May 1, 2025, of its intent to cure the deficiency and will consider available alternatives, subject to stockholder approval. During this period, NRGV's common stock will continue to trade on the NYSE.

Positive

• Six-month grace period granted to cure listing deficiency
• Continued NYSE trading during cure period

Negative

• Stock price fallen below NYSE minimum requirement of $1.00
• Risk of potential NYSE delisting if compliance not achieved
• Required stockholder approval for potential cure actions

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)-- Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that it received notice from the New York Stock Exchange (the “NYSE”) on April 16, 2025, indicating that Energy Vault is not in compliance with NYSE’s continued listing standards because the average closing price of Energy Vault’s common stock was less than $1.00 over a consecutive 30 trading-day period.

Under NYSE rules, Energy Vault has a period of six months from receipt of the notice to regain compliance with the NYSE minimum stock price listing requirement. Energy Vault plans to notify the NYSE by May 1, 2025 of its intent to cure the stock price deficiency and return to compliance with the NYSE continued listing standards.

Energy Vault intends to consider available alternatives, subject to stockholder approval, to cure the stock price non-compliance. Under the NYSE’s rules, if Energy Vault determines that it will cure the stock price deficiency by taking an action that will require stockholder approval, the price condition will be deemed cured if the price promptly exceeds $1.00 per share, and the price remains above that level for at least the following 30 trading days. Energy Vault’s common stock will continue to be listed and trade on the NYSE during this cure period.

About Energy Vault

Energy Vault^® develops, deploys and operates utility-scale energy storage solutions designed to transform the world's approach to sustainable energy storage. The Company's comprehensive offerings include proprietary battery, gravity and green hydrogen energy storage technologies supporting a variety of customer use cases delivering safe and reliable energy system dispatching and optimization. Each storage solution is supported by the Company’s technology-agnostic energy management system software and integration platform. Unique to the industry, Energy Vault’s innovative technology portfolio delivers customized short, long and multi-day/ultra-long duration energy storage solutions to help utilities, independent power producers, and large industrial energy users significantly reduce levelized energy costs while maintaining power reliability. Please visit www.energyvault.com for more information.

Forward-Looking Statements

This press release includes forward-looking statements that reflect the Company’s current views with respect to, among other things, the Company’s operations and financial performance. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “project,” “forecast,” “estimates,” “targets,” “projections,” “should,” “could,” “would,” “may,” “might,” “will” and other similar expressions. We base these forward-looking statements or projections on our current expectations, plans and assumptions, which we have made in light of our experience in our industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at the time. These forward-looking statements are based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to us. These forward-looking statements are only predictions based upon our current expectations and projections about future events. These forward-looking statements involve significant risks and uncertainties that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including changes in our strategy, expansion plans, customer opportunities, future operations, future financial position, estimated revenues and losses, projected costs, prospects and plans; the implementation, market acceptance and success of our business model and growth strategy; our ability to develop and maintain our brand and reputation; developments and projections relating to our business, our competitors, and industry; the impact of macroeconomic uncertainty, including with respect to uncertainty about the future relationship between the United States and other countries with respect to trade policies, taxes, government regulations, and tariffs; investment in development projects that may not achieve commercial operations in our predicted timeframe or at all; our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others; expectations regarding the time during which we will be an emerging growth company under the JOBS Act; our future capital requirements and sources and uses of cash; our ability to obtain funding for our operations and future growth; our business, expansion plans and opportunities and other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024, as such factors may be updated from time to time in its other filings with the SEC, accessible on the SEC’s website at www.sec.gov. New risks emerge from time to time and it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Any forward-looking statement made by us in this press release speaks only as of the date of this press release and is expressly qualified in its entirety by the cautionary statements included in this press release. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable laws. You should not place undue reliance on our forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250417711109/en/

Investors:

energyvaultIR@icrinc.com

Media:

media@energyvault.com

Source: Energy Vault Holdings, Inc.

FAQ

What happens if Energy Vault (NRGV) stock stays below $1.00?

If NRGV fails to cure the price deficiency within the six-month period, it risks being delisted from the NYSE.

How long does Energy Vault (NRGV) have to get its stock price above $1.00?

Energy Vault has six months from April 16, 2025, to regain compliance with NYSE's minimum $1.00 stock price requirement.

What options does Energy Vault (NRGV) have to cure the NYSE listing deficiency?

The company can consider various alternatives subject to stockholder approval, and must maintain the stock price above $1.00 for at least 30 consecutive trading days.

Will Energy Vault (NRGV) continue trading on NYSE during the cure period?

Yes, Energy Vault's common stock will continue to be listed and trade on the NYSE during the six-month cure period.